We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has hit three more compounders — two in California and one in North Carolina — with warning letters, bringing to 25 the number of warnings issued to this industry last year. Read More
To reduce medication errors, CDER on Friday released its revised policies and procedures on proprietary naming of drugs, which are sometimes misidentified because of the way they are spelled or how the names sound. Read More
Two House members are asking two embattled drugmakers for information and documents related to some of their products ahead of a Jan. 26 hearing on prescription drug pricing. Read More
Drugmakers have asked the FDA to think “globally” with the international community as they weighed in on the agency’s draft guidance on established conditions for reporting chemical, manufacturing and control changes. Read More
Ohio Secretary of State John Husted is facing a lawsuit for failing to transmit the proposed Ohio Drug Price Relief Act citizen petition to the state’s General Assembly, as required by the state’s constitution. Read More